stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) EPS (diluted)
Alcon's EPS (diluted) for fiscal 2025 was $1.98, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $1.31. Over the past ten years it has ranged from −$1.34 (fiscal 2019) to $2.05 (fiscal 2024); the current reading is higher than 90% of that period. Alcon ranks 16th of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $1.98 | (3.41%) |
| FY2024 | $2.05 | 4.59% |
| FY2023 | $1.96 | 188.24% |
| FY2022 | $0.68 | (10.53%) |
| FY2021 | $0.76 | — |
| FY2020 | −$1.09 | — |
| FY2019 | −$1.34 | — |
| FY2018 | −$0.47 | — |
| FY2017 | $0.53 | — |
| FY2016 | −$0.33 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $0.00 | — |
| Mar 2026 | $0.39 | (11.36%) |
| Dec 2025 | $0.44 | (8.33%) |
| Sep 2025 | $0.48 | 37.14% |
| 28 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| RMD ResMed Inc. compare | $10.98 |
| WST West Pharmaceutical Services, Inc. compare | $8.91 |
| ALGN Align Technology, Inc. compare | $6.87 |
| BDX Becton, Dickinson and Company compare | $3.32 |
| COO The Cooper Companies, Inc. compare | $2.93 |
| ALC Alcon | $1.31 |
| SOLV Solventum Corporation compare | $0.89 |
| MDLN Medline Inc. compare | $0.68 |
| BAX Baxter International Inc. compare | −$1.41 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on ALC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement